Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
SHH: 603168.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Xiusong Lin
- Employees
- 1,385
- Headquarters
- Pinghu, China
- IPO year
- 2014
- Market cap
- CN¥2.5B
- Website
- https://www.zjspas.com
Loading 603168…
Loading profile data…Frequently asked questions about 603168
What does Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS) do?
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antipyretic and analgesic, antibacterial anti-inflammatory, endocrine, auxiliary, cardiovascular, detoxification, diuretic row stone, gynecology, and infusion cat...
Where does 603168.SS trade?
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS) trades on the Shanghai Stock Exchange.
What sector is 603168.SS in?
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.?
Xiusong Lin is the chief executive officer of Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS).
Where is Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. headquartered?
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is headquartered in China.
Does 603168.SS pay a dividend?
Yes — Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS) paid a trailing twelve-month dividend of CNY 0.02 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603168.SS go public?
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS) completed its initial public offering in 2014.